E
PTVE

Ergoteles’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Ergoteles’s Portfolio PTVE Stock Details PTVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,545
Closed -$248K – 1698
2021
Q4 		$248K Buy
+19,545
New +$254K 0.01% 927

Other funds holding PTVE

American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's PTVE Position: Q1 2022 in Review

Ergoteles sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q1 2022, closing a stake of 19,545 shares — an estimated $248K sold.

Ergoteles first reported a position in PTVE in Q4 2021 and held it in 1 quarter. The position peaked at $248K in Q4 2021. 103 funds tracked by Wall St. Rank hold PTVE as of Q1 2022.

  • Ergoteles reported no remaining Pactiv Evergreen Inc. Common stock position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 19,545 Pactiv Evergreen Inc. Common stock shares in Q1 2022, an estimated $248K.
  • Ergoteles first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2021 and held it in 1 quarter.
  • Ergoteles's Pactiv Evergreen Inc. Common stock position peaked at $248K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.